Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Chin J Integr Med ; 29(9): 832-837, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37222831

ABSTRACT

OBJECTIVE: To compare the clinical effect of arsenic-containing Qinghuang Powder (QHP) and low-intensity chemotherapy (LIC) in treatment of elderly acute myeloid leukemia (eAML) patients. METHODS: Clinical data of 80 eAML patients treated at Xiyuan Hospital of China Academy of Chinese Medical Sciences from January 2015 to December 2020 were retrospectively analyzed. The treatment scheme was designed by real world study according to patients' preference, and patients were divided into a QHP group (35 cases) and a LIC group (45 cases). The median overall survival (mOS), 1-, 2-, and 3-year OS rates, and incidence of adverse events were compared between the two groups. RESULTS: The mOS of 80 patients was 11 months, and the 1-, 2-, and 3-year OS rates were 45.51%, 17.96%, and 11.05%, respectively. The QHP and LIC groups demonstrated no significant difference in mOS (12 months vs. 10 months), 1- (48.57% vs. 39.65%), 2- (11.43% vs. 20.04%), and 3-year OS rates (5.71% vs. 13.27%, all P>0.05). Moreover, the related factors of mOS demonstrated no significant difference in patients with age>75 years (11 months vs. 8 months), secondary AML (11 months vs. 8 months), poor genetic prognosis (9 months vs. 7 months), Eastern Cooperative Oncology Group performance status score ⩾ 3 (10 months vs. 7 months) and hematopoietic stem cell transplant comorbidity index ⩾ 4 (11 months vs. 7 months) between the QHP and LIC groups (all P>0.05). However, the incidence of myelosuppression was significantly lower in the QHP group than that in the LIC group (28.57% vs. 73.33%, P<0.01). CONCLUSIONS: QHP and LIC had similar survival rates in eAML patients, but QHP had a lower myelosuppression incidence. Hence, QHP can be an alternative for eAML patients who do not tolerate LIC.


Subject(s)
Arsenic , Leukemia, Myeloid, Acute , Humans , Aged , Arsenic/therapeutic use , Powders/therapeutic use , Retrospective Studies , Leukemia, Myeloid, Acute/drug therapy , Prognosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use
2.
Ying Yong Sheng Tai Xue Bao ; 21(5): 1217-23, 2010 May.
Article in Chinese | MEDLINE | ID: mdl-20707104

ABSTRACT

Brilliant blue dyeing and water breakthrough curve were applied to study the number and distribution of macropores and their relations to the preferential flow in typical sub-tropic broad-leaved forest soils of Simian Mountains. The radii of the macropores were mainly between 0. 3 and 3.0 mm, with the macroporosities in the range of 6.3% to 10.5%, and the macropores were always distributed in aggregation with increasing soil depth. The number of the macropores in each radius interval of dye-stained areas was tenfold increase than that of blank areas. The number of the macropores with radius larger than 0.3 mm, especially larger than 1.5 mm, was the most important factor affecting the occurrence of preferential flow. Significant correlations were found between the number of macropores and the water steady effluent volume, with the highest correlation coefficients of 0.842 and 0.879 for the radii intervals of 0.7-1.5 mm and 1.5-3.0 mm, respectively. Macro-pore continuity in dye-stained areas was better than that in blank areas, especially in the radius interval of 1.5-3.0 mm, with the biggest difference of 78.31%. In dye-stained areas, the number of macropores decreased gradually with soil depth. The filler-like distribution of macropores formed an effective water pressure gradient, which resulted in the preferential transport of water.


Subject(s)
Ecosystem , Soil/analysis , Trees/growth & development , Water Movements , Water/metabolism , China , Porosity , Quercus/growth & development , Water/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...